{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:02:20Z","timestamp":1778695340209,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2015ZX09102021"],"award-info":[{"award-number":["2015ZX09102021"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.06.021","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T21:02:57Z","timestamp":1656104577000},"page":"4716-4725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain"],"prefix":"10.1016","volume":"40","author":[{"given":"Gang","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Yun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng-Li","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2022.06.021_b0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10096-018-3206-x","article-title":"Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention","volume":"37","author":"Esposito","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77768-7","article-title":"Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China","volume":"10","author":"Meng","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2022.06.021_b0015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/0009922820910822","article-title":"The epidemiological and clinical characteristics of Hand, Foot, and Mouth Disease in Hangzhou, China, 2016 to 2018","volume":"59","author":"Wang","year":"2020","journal-title":"Clin Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.021_b0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1749-6632.1953.tb30251.x","article-title":"The coxsackie virus group","volume":"56","author":"Dalldorf","year":"1953","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.021_b0025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3181\/00379727-90-22088","article-title":"Recently classified types of coxsackie virus, group A; behavior in tissue culture","volume":"90","author":"Sickles","year":"1955","journal-title":"Proc Soc Exp Biol Med"},{"issue":"18","key":"10.1016\/j.vaccine.2022.06.021_b0030","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1128\/JVI.01567-12","article-title":"Complete genome sequence of two coxsackievirus A1 strains that were cytotoxic to human rhabdomyosarcoma cells","volume":"86","author":"Sun","year":"2012","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.021_b0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2022.06.021_b0040","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1099\/0022-1317-78-8-1829","article-title":"Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae","volume":"78","author":"Rombaut","year":"1997","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.06.021_b0045","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01743-20","article-title":"Efficacy of coxsackievirus A5 vaccine candidates in an actively immunized mouse model","volume":"95","author":"Jin","year":"2021","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.021_b0050","first-page":"1132","article-title":"Immunogenicity of full and empty particles of coxsackievirus A16. Chin","volume":"28","author":"Zhang","year":"2016","journal-title":"J Biologicals"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.021_b0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1684-1182(10)60016-3","article-title":"Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children\u2019s hospital experience","volume":"43","author":"Chen","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.021_b0065","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1201-9712(03)90010-5","article-title":"Enterovirus isolation from children with acute respiratory infections and presumptive identification by a modified microplate method","volume":"7","author":"Mizuta","year":"2003","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0070","first-page":"111","article-title":"High prevalence of coxsackievirus A2 in children with herpangina in Thailand in 2015","volume":"28","author":"Chansaenroj","year":"2017","journal-title":"Virus disease"},{"key":"10.1016\/j.vaccine.2022.06.021_b0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcv.2015.11.024","article-title":"Enterovirus infections in hospitals of Ile de France region over 2013","volume":"74","author":"Molet","year":"2016","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pedneo.2018.02.003","article-title":"Outbreak of recombinant coxsackievirus A2 infection and polio-like paralysis of children, Taiwan, 2014","volume":"60","author":"Chiang","year":"2019","journal-title":"Pediatr Neonatol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.06.021_b0085","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1099\/jmm.0.027698-0","article-title":"An echovirus 18-associated outbreak of aseptic meningitis in Taiwan: epidemiology and diagnostic and genetic aspects","volume":"60","author":"Tsai","year":"2011","journal-title":"J Med Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2022.06.021_b0090","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3201\/eid1908.121498","article-title":"Recombinant coxsackievirus A2 and deaths of children, Hong Kong, 2012","volume":"19","author":"Yip","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0095","doi-asserted-by":"crossref","first-page":"35388","DOI":"10.1038\/srep35388","article-title":"Outbreak of herpangina in children caused by enterovirus in summer of 2015 in Hangzhou, China","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.021_b0100","first-page":"1262","article-title":"Molecular epidemiological analysis of enteroviruses associated with hand, foot and mouth disease in Wuhan in 2018. Chin","volume":"33","author":"Xu","year":"2020","journal-title":"J Biologicals"},{"key":"10.1016\/j.vaccine.2022.06.021_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.658093","article-title":"Neonatal murine model of coxsackievirus A2 infection for the evaluation of antiviral therapeutics and vaccination","volume":"12","author":"Ji","year":"2021","journal-title":"Front Microbiol"},{"issue":"30","key":"10.1016\/j.vaccine.2022.06.021_b0110","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2017.05.057","article-title":"Optimized production and purification of coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model","volume":"35","author":"Hankaniemi","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/jvi.65.1.326-334.1991","article-title":"Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2","volume":"65","author":"Harber","year":"1991","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0120","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/22221751.2021.1906755","article-title":"Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model","volume":"10","author":"Qian","year":"2021","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1423-0127-21-31","article-title":"Animal models of enterovirus 71 infection: applications and limitations","volume":"21","author":"Wang","year":"2014","journal-title":"J Biomed Sci"},{"issue":"21","key":"10.1016\/j.vaccine.2022.06.021_b0130","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","article-title":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","volume":"32","author":"Cai","year":"2014","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2022.06.021_b0135","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1016\/j.vaccine.2016.08.033","article-title":"Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge","volume":"34","author":"Shen","year":"2016","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2022.06.021_b0140","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1016\/j.vaccine.2018.09.069","article-title":"Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice","volume":"36","author":"Zhang","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0145","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1080\/22221751.2019.1673135","article-title":"A neonatal murine model of coxsackievirus A4 infection for evaluation of vaccines and antiviral drugs","volume":"8","author":"Zhang","year":"2019","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2022.06.021_b0150","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/v10120674","article-title":"Immunocompetent and immunodeficient mouse models for enterovirus 71 pathogenesis and therapy","volume":"10","author":"Shih","year":"2018","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.021_b0155","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1128\/JVI.06103-11","article-title":"A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection","volume":"86","author":"Khong","year":"2012","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2022.06.021_b0160","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2018.05.005","article-title":"The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease","volume":"36","author":"Lim","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0168-1702(00)00235-5","article-title":"Complete nucleotide sequence and cell-line multiplication pattern of the attenuated variant CH2195LA of Japanese encephalitis virus","volume":"73","author":"Wu","year":"2001","journal-title":"Virus Res"},{"issue":"19","key":"10.1016\/j.vaccine.2022.06.021_b0170","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1128\/JVI.01370-16","article-title":"A single mutation in the VP1 of enterovirus 71 is responsible for increased virulence and neurotropism in adult interferon-deficient mice","volume":"90","author":"Caine","year":"2016","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.021_b0175","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.antiviral.2012.12.010","article-title":"Development and characterization of a stable eGFP enterovirus 71 for antiviral screening","volume":"97","author":"Shang","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2022.06.021_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2017.00171","article-title":"Dynamic interaction of enterovirus 71 and dendritic cells in infected neonatal rhesus macaques","volume":"7","author":"Zhao","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2022.06.021_b0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jviromet.2015.03.020","article-title":"Development of a stable Gaussia luciferase enterovirus 71 reporter virus","volume":"219","author":"Xu","year":"2015","journal-title":"J Virol Methods"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.021_b0190","doi-asserted-by":"crossref","first-page":"e01586","DOI":"10.1128\/JVI.01586-16","article-title":"Increasing type 1 poliovirus capsid stability by thermal selection","volume":"91","author":"Adeyemi","year":"2017","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.021_b0195","doi-asserted-by":"crossref","first-page":"e1006117","DOI":"10.1371\/journal.ppat.1006117","article-title":"Genetically thermo-stabilised, immunogenic poliovirus empty capsids; a strategy for non-replicating vaccines","volume":"13","author":"Fox","year":"2017","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.vaccine.2022.06.021_b0200","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1099\/0022-1317-70-6-1453","article-title":"Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector","volume":"70","author":"Urakawa","year":"1989","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.021_b0205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/imcb.12312","article-title":"The protective potential of Fc mediated antibody functions against influenza virus and other viral pathogens","volume":"98","author":"Vanderven","year":"2020","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2022.06.021_b0210","doi-asserted-by":"crossref","unstructured":"Lim HX, Poh CL. Insights into innate and adaptive immune responses in vaccine development against EV-A71. Ther Adv Vaccines Immunother 2019;7: 2515135519888998. https:\/\/doi.org\/10.1177\/2515135519888998.","DOI":"10.1177\/2515135519888998"},{"issue":"11","key":"10.1016\/j.vaccine.2022.06.021_b0215","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.7150\/ijms.26450","article-title":"T cell immunity to enterovirus 71 infection in humans and implications for vaccine development","volume":"15","author":"Yee","year":"2018","journal-title":"Int J Med Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200768X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2200768X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:14:43Z","timestamp":1759403683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2200768X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":43,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X2200768X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}